Personalized Treatment of Advanced Gastric Cancer Guided by the MiniPDX Model.

Jianzheng WangJinxi HuangHui WangWei YangQiwen BaiZhentao YaoQingli LiHuifang LvBeibei ChenCaiyun NieWeifeng XuShuiping TuHongle LiXiao-Bing Chen

Published in: Journal of oncology (2022)

Establishing a personalized drug screening system for patients with drug-resistant gastric cancer can guide the selection of clinical drugs, improve the clinical benefit of patients, and avoid ineffective treatments. It can be an effective supplement for treatment options.

Keyphrases

drug resistant
multidrug resistant
end stage renal disease
acinetobacter baumannii
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
radiation therapy
squamous cell carcinoma
lymph node
adverse drug